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Continuing Medical Education (CME) can be defined
‘educational activities that serve to maintain, develop,
or increase the knowledge, skills and professional
performance (and) relationships used by a physician
to provide services for patients, the public, or the
profession’.1 It is a professional responsibility for all
practicing physicians and it has become increasingly
important in a fast moving medical world.
Many CME activities are organized on a national level.
For CME organized on a European level, the European
Board of Vascular Surgery of the UEMS (Union
Europe´enne des Me´dicins Spe´cialistes) has accepted
a responsibility concerning the quality of these CME
activities. It is important to realize that the EBVS is not
a provider of Continuing Medical Education (CME)
but must be seen as an independent authority that by
its activities may assist as a clearinghouse for CME
credits from a European to a national level. The EBVS
has proposed accreditation for European Vascular
CME activities since 1999.2 The CME Committee has
been very active and accredits many European
vascular meetings each year according to simple
published criteria. Criteria for CME initially focused
on major meetings in order to ensure that our criteria
were reliable. CME activities have now been extended
to technical skills workshops, again with specific and
transparent criteria.
Why are guidelines necessary? Traditionally, the
pharmaceutical and medical device manufacturers
have generously supported CME for physicians.
Without industrial support, the quality of many
activities would have been reduced and some activi-
ties would have been cancelled. During the last decade
physicians, editorial boards of scientific journals and
authorities have increasingly scrutinised the role of
industry supporting these activities.3 – 5 The basis for
the concern is that scientific activities may be used for
promotional activities without clearly identifying
these activities. In 1993, Mannick reported on the
‘scientific symposium’ grafted onto the national meet-
ings. For many of these both the programme and the
speakers were picked and sponsored by a company.
Under these circumstances an unbiased presentation
is difficult to attain.6 It is clear that a conflict of interest
may easily occur if organizers of CME activities need
the support of the industry. In fact, travel funds,
honoraria for nominal consultancies, free lunches,
elegant dinners accompanied by product demon-
strations and guest lectures with favourable views of
the sponsors’ products all threaten our integrity.7
Fortunately, both CME providers and the industry
have recognized this issue and both are keen to resolve
the problem.
The CME Committee of the European Board of
Vascular Surgery has discussed this issue at length and
believes that for both CME providers and industry, as
well as for the participants of CME activities, it would
be helpful to provide clear and objective guidelines
describing the relationship between the various
parties. These guidelines are meant to stimulate a
healthy and clear relationship between organizers of
CME activities and the industry. The EBVS of the
UEMS approved these Guidelines on 2nd September
2003 in Dublin. The Guidelines are published on the
website of the EBVS and will be handed to both CME
providers and the industry. For practical purposes the
Guidelines have been subdivided into those for
providers of CME activities, speakers and faculty
and industrial sponsors. The Guidelines will be
evaluated regularly and comments are encouraged.
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Introduction
Continuing Medical Education (CME) consists of
educational activities that serve to maintain, develop,
or increase the knowledge, skills and/or professional
performance of a physician. CME is provided by CME
providers by means of organizing conferences, work-
shops, etc. and is an important element of Continuing
Physician Professional Development (CPPD). Providers
of CME are responsible for the provision of objective,
balanced and scientifically rigorous information. CME
should not be biased.
The relationship between the provision of edu-
cational activities and industrial support is essential
and acknowledged with gratitude. Subsidies to under-
write the costs of CME activities can contribute to the
improvement of those activities and help to reduce the
costs of the activity for the participants. However,
financial support should never influence the content
and quality of the scientific programme. Therefore,
financial support from the industry should come in the
form of an educational grant with grateful ack-
nowledgement. The need for financial (industrial)
support may generate a conflict of interest for the
provider of CME or the faculty. To prevent such a
conflict of interest, the European Board of Vascular
Surgery has established the following guidelines to
assist both parties.
Guidelines
For organizers of CME activities
. Physicians involved in providing CME activities
should ensure that the programme is balanced.
. Physicians who serve as presenters, moderators, or
other faculty at CME conferences should ensure
that research findings and therapeutic recommen-
dations are based upon scientifically accurate, up-
to-date information and are presented in a
balanced, objective manner.
. All potential conflicts of interest or biases, such as a
financial connection to a particular commercial
company or product, should be disclosed by
faculty members to the audience in the programme
and/or at the beginning of a presentation.
. A direct financial relationship between speakers
and industry should be discouraged. Speakers and
faculty should not accept direct subsidies from
industry to pay for the costs of travel, lodging, or
other personal expenses. Costs should be reim-
bursed by the organizer/provider of the CME
activities.
. The scientific programme committee is responsible
for moderators, presenters and other faculty and
welcome suggestions from those companies that
have been generous enough to support the pro-
gramme. Clearly, the responsibility for the mod-
erators, presenters and other faculty lies with the
scientific committee.
. Non-CME activities, i.e. primarily promotional
seminars, should be clearly identified as such in
the programme.
For speakers and other faculty
. Speakers and other faculty involved in providing
CME activities should present a range of scientifi-
cally supportable viewpoints related to the topics.
. Speakers and other faculty who present, chair or
moderate, at CME conferences should ensure that
research findings and therapeutic recommen-
dations are based on scientifically accurate, up-to-
date information and are presented in a balanced,
objective manner.
. All conflicts of interest should be disclosed by
faculty members to the audience in the programme
and/or at the beginning of a presentation.
. A direct financial relationship between speakers or
other faculty and industry should be discouraged.
Speakers and faculty should not accept direct
subsidies from industry to pay for the costs of
travel, lodging, or other personal expenses. Costs
should be reimbursed by the organizer/provider of
the CME activities.
. Non-CME activities, i.e. primarily promotional
seminars, should be clearly identified as such in
the programme.
For industrial sponsors
. Financial support of CME activities is greatly
appreciated by the organisers of CME activities
and it is gratefully recognized that these activities
would not be viable without industrial sponsor-
ship. The support should be provided by edu-
cational grants to the organisers of the CME
activities.
. A direct financial relationship between speakers or
other faculty and industry should be discouraged.
Speakers and faculty should not offer direct
subsidies from industry to pay for the costs of
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travel, lodging, or other personal expenses. Costs
should be reimbursed by the organizer/provider of
the CME activities.
. The scientific programme committee is responsible
for moderators, presenters and other faculty.
Suggestions from those companies that have been
generous enough to support the programme are
welcome. However, the responsibility for the
moderators, presenters and other faculty lies with
the scientific committee.
. CME symposia supported by a sponsor should be
fully acknowledged in the appropriate section of
the programme. However, a company name in the
title of the symposium unintentionally suggests a
promotional relationship. For this reason sponsor
names should not be included in the title of the
CME symposium.
. Non-CME activities, i.e. primarily promotional
seminars, should be clearly identified in the
programme.
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